Patient retention in antiretroviral therapy programs in sub-Saharan Africa: a systematic review

S Rosen, MP Fox, CJ Gill - PLoS medicine, 2007 - journals.plos.org
Background Long-term retention of patients in Africa's rapidly expanding antiretroviral
therapy (ART) programs for HIV/AIDS is essential for these programs' success but has …

Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa

SD Lawn, AD Harries, X Anglaret, L Myer, R Wood - Aids, 2008 - journals.lww.com
Two-thirds of the world's HIV-infected people live in sub-Saharan Africa, and more than 1.5
million of them die annually. As access to antiretroviral treatment has expanded within the …

Development of a standardized screening rule for tuberculosis in people living with HIV in resource-constrained settings: individual participant data meta-analysis of …

H Getahun, W Kittikraisak, CM Heilig, EL Corbett… - PLoS …, 2011 - journals.plos.org
Background The World Health Organization recommends the screening of all people living
with HIV for tuberculosis (TB) disease, followed by TB treatment, or isoniazid preventive …

Quantifying and addressing losses along the continuum of care for people living with HIV infection in sub‐Saharan Africa: a systematic review

K Kranzer, D Govindasamy, N Ford… - African Journal of …, 2012 - journals.lww.com
Introduction: Recent years have seen an increasing recognition of the need to improve
access and retention in care for people living with HIV/AIDS. This review aims to quantify …

Diagnostic accuracy of a low-cost, urine antigen, point-of-care screening assay for HIV-associated pulmonary tuberculosis before antiretroviral therapy: a descriptive …

SD Lawn, AD Kerkhoff, M Vogt… - The Lancet infectious …, 2012 - thelancet.com
Background The diagnostic accuracy of sputum smear microscopy and routine chest
radiology for HIV-associated tuberculosis is poor, and culture-based diagnosis is slow …

Screening for HIV-associated tuberculosis and rifampicin resistance before antiretroviral therapy using the Xpert MTB/RIF assay: a prospective study

SD Lawn, SV Brooks, K Kranzer, MP Nicol… - PLoS …, 2011 - journals.plos.org
Background The World Health Organization has endorsed the Xpert MTB/RIF assay for
investigation of patients suspected of having tuberculosis (TB). However, its utility for routine …

Loss to programme between HIV diagnosis and initiation of antiretroviral therapy in sub‐Saharan Africa: systematic review and meta‐analysis

C Mugglin, J Estill, G Wandeler… - Tropical Medicine & …, 2012 - Wiley Online Library
Objectives To assess the proportion of patients lost to programme (died, lost to follow‐up,
transferred out) between HIV diagnosis and start of antiretroviral therapy (ART) in sub …

Short-term and long-term risk of tuberculosis associated with CD4 cell recovery during antiretroviral therapy in South Africa

SD Lawn, L Myer, D Edwards, LG Bekker, R Wood - Aids, 2009 - journals.lww.com
Objective: To determine the short-term and long-term risks of tuberculosis (TB) associated
with CD4 cell recovery during antiretroviral therapy (ART). Design: Observational community …

Screening for cryptococcal antigenemia in patients accessing an antiretroviral treatment program in South Africa

JN Jarvis, SD Lawn, M Vogt, N Bangani… - Clinical infectious …, 2009 - academic.oup.com
Background. Cryptococcal meningitis is a leading cause of death in patients with acquired
immunodeficiency syndrome and contributes substantially to the high early mortality in …

Comparison and temporal trends of three groups with cryptococcosis: HIV-infected, solid organ transplant, and HIV-negative/non-transplant

EW Bratton, N El Husseini, CA Chastain, MS Lee… - 2012 - journals.plos.org
Background The Infectious Disease Society of America (IDSA) 2010 Clinical Practice
Guidelines for the management of cryptococcosis outlined three key populations at risk of …